BN Business News
Add your company to Business Communicator →

Regulation & law · 26/07/2012Updated: 10/17/2026 · 1 min read

Nektar Therapeutics Submits Application for New Controlled Substance, Seeking FDA Approval

Summary

Nektar Therapeutics has submitted a notice of application to the FDA for a new controlled substance, as part of its ongoing efforts to develop innovative treatments for various medical conditions.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights

Business insights →